88 related articles for article (PubMed ID: 3048498)
1. Renal involvement in chronic graft-versus-host disease: a report of two cases.
Gomez-Garcia P; Herrera-Arroyo C; Torres-Gomez A; Gomez-Carrasco J; Aljama-Garcia P; Lopez-Rubio F; Martinez-Guibelalde F; Fornes-Torres G; Rojas-Contreras R
Bone Marrow Transplant; 1988 Jul; 3(4):357-62. PubMed ID: 3048498
[TBL] [Abstract][Full Text] [Related]
2. Isolated testicular and bone relapse in children with acute myeloblastic leukemia and chronic graft versus host disease after allogeneic BMT.
Yildirim I; Uçkan D; Cetin M; Tuncer M; Tezcan I
Turk J Pediatr; 2007; 49(2):206-9. PubMed ID: 17907524
[TBL] [Abstract][Full Text] [Related]
3. Nephrotic syndrome in a bone marrow transplant recipient with chronic graft-versus-host disease.
Sato N; Kishi K; Yagisawa K; Kasama J; Karasawa R; Shimada H; Nishi S; Ueno M; Ito K; Koike T
Bone Marrow Transplant; 1995 Aug; 16(2):303-5. PubMed ID: 7581152
[TBL] [Abstract][Full Text] [Related]
4. Gastrointestinal involvement in chronic graft-versus-host disease: a clinicopathologic study.
Akpek G; Chinratanalab W; Lee LA; Torbenson M; Hallick JP; Anders V; Vogelsang GB
Biol Blood Marrow Transplant; 2003 Jan; 9(1):46-51. PubMed ID: 12533741
[TBL] [Abstract][Full Text] [Related]
5. Chronic intestinal graft-versus-host disease: clinical, histological and immunohistochemical analysis of 17 children.
Patey-Mariaud de Serre N; Reijasse D; Verkarre V; Canioni D; Colomb V; Haddad E; Brousse N
Bone Marrow Transplant; 2002 Feb; 29(3):223-30. PubMed ID: 11859394
[TBL] [Abstract][Full Text] [Related]
6. Interstitial pneumonitis, pulmonary fibrosis, and chronic graft-versus-host disease.
Kaplan EB; Pietra GG; August CS
Bone Marrow Transplant; 1992 Jan; 9(1):71-5. PubMed ID: 1543954
[TBL] [Abstract][Full Text] [Related]
7. Graft-versus-host disease following bone marrow transplantation: clinical feature and diagnosis.
Kikuta A; Suzuki H
Fukushima J Med Sci; 1993 Dec; 39(2):95-9. PubMed ID: 7927140
[TBL] [Abstract][Full Text] [Related]
8. Soft tissue sarcoma in the setting of chronic cutaneous graft versus host disease after allogenic bone marrow transplantation.
Bylund KC; Giampoli E; Singh D; Doerr T; Sahasrabudhe D; Liesveld J; Constine LS
Cancer Invest; 2008 Jul; 26(6):638-41. PubMed ID: 18584356
[TBL] [Abstract][Full Text] [Related]
9. Prognostic factors for long-term survival in leukemic marrow recipients with special emphasis on age and prophylaxis for graft-versus-host disease.
Aschan J; Ringdén O
Clin Transplant; 1994 Jun; 8(3 Pt 1):258-70. PubMed ID: 8061365
[TBL] [Abstract][Full Text] [Related]
10. Chronic graft-versus-host disease in children and adolescents after bone marrow transplantation from HLA-matched donors.
Yumura-Yagi K; Inoue M; Sakata N; Okamura T; Yasui M; Nakano T; Nomura K; Nakano T; Park DY; Endo C; Nishiuchi R; Sawada A; Matsuda Y; Oota H; Yoshimoto T; Kawa-Ha K
Int J Hematol; 2000 Apr; 71(3):278-82. PubMed ID: 10846836
[TBL] [Abstract][Full Text] [Related]
11. Atypical acute graft-versus-host disease.
Shin J; Hong W; Song H; Choi G; Kim YC
Am J Dermatopathol; 2007 Dec; 29(6):576-7. PubMed ID: 18032957
[TBL] [Abstract][Full Text] [Related]
12. Close simulation of acute graft-versus-host disease by interleukin-2 administered after autologous bone marrow transplantation for hematologic malignancy.
Massumoto C; Benyunes MC; Sale G; Beauchamp M; York A; Thompson JA; Buckner CD; Fefer A
Bone Marrow Transplant; 1996 Mar; 17(3):351-6. PubMed ID: 8704686
[TBL] [Abstract][Full Text] [Related]
13. Prognostic factors of chronic graft-versus-host disease after allogeneic blood stem-cell transplantation.
Pavletic SZ; Smith LM; Bishop MR; Lynch JC; Tarantolo SR; Vose JM; Bierman PJ; Hadi A; Armitage JO; Kessinger A
Am J Hematol; 2005 Apr; 78(4):265-74. PubMed ID: 15795914
[TBL] [Abstract][Full Text] [Related]
14. Acute graft-versus-host disease of the heart.
Roberts SS; Leeborg N; Loriaux M; Johnson FL; Huang ML; Stenzel P; Thiede C; Godder KT
Pediatr Blood Cancer; 2006 Oct; 47(5):624-8. PubMed ID: 16206193
[TBL] [Abstract][Full Text] [Related]
15. Chronic graft-versus-host disease after allogeneic bone marrow transplantation from an unrelated donor: incidence, risk factors and association with relapse. A report from the Japan Marrow Donor Program.
Ozawa S; Nakaseko C; Nishimura M; Maruta A; Cho R; Ohwada C; Sakamaki H; Sao H; Mori S; Okamoto S; Miyamura K; Kato S; Kawase T; Morishima Y; Kodera Y;
Br J Haematol; 2007 Apr; 137(2):142-51. PubMed ID: 17391494
[TBL] [Abstract][Full Text] [Related]
16. Ocular manifestations of graft versus host disease following bone marrow transplantation.
Claes K; Kestelyn P
Bull Soc Belge Ophtalmol; 2000; (277):21-6. PubMed ID: 11126670
[TBL] [Abstract][Full Text] [Related]
17. Progressive interstitial fibrosis of the lung in sclerodermoid chronic graft-versus-host disease.
Wolff D; Reichenberger F; Steiner B; Kahl C; Leithäuser M; Skibbe T; Friedrich T; Terpe H; Helbig W; Freund M
Bone Marrow Transplant; 2002 Feb; 29(4):357-60. PubMed ID: 11896434
[TBL] [Abstract][Full Text] [Related]
18. Graft-versus-host disease after marrow transplantation.
Storb R
Prog Clin Biol Res; 1986; 224():139-57. PubMed ID: 3540990
[TBL] [Abstract][Full Text] [Related]
19. Graft-versus-leukemia effects in T lineage and B lineage acute lymphoblastic leukemia.
Passweg JR; Tiberghien P; Cahn JY; Vowels MR; Camitta BM; Gale RP; Herzig RH; Hoelzer D; Horowitz MM; Ifrah N; Klein JP; Marks DI; Ramsay NK; Rowlings PA; Weisdorf DJ; Zhang MJ; Barrett AJ
Bone Marrow Transplant; 1998 Jan; 21(2):153-8. PubMed ID: 9489632
[TBL] [Abstract][Full Text] [Related]
20. A second prophylactic MHC-mismatched bone marrow transplantation protects against rat acute myeloid leukemia (BNML) without lethal graft-versus-host disease.
Nestvold JM; Omdal BK; Dai KZ; Martens A; Benestad HB; Vaage JT; Rolstad B
Transplantation; 2008 Jan; 85(1):102-11. PubMed ID: 18192919
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
